Research Article

Serum microRNA expression in pregnancies with preeclampsia

Published: November 08, 2011
Genet. Mol. Res. 10 (4) : 4034-4040 DOI: https://doi.org/10.4238/2011.November.8.5
Cite this Article:
T. Gunel, Y.G. Zeybek, P. Akçakaya, I. Kalelioglu, A. Benian, H. Ermis, K. Aydinli (2011). Serum microRNA expression in pregnancies with preeclampsia. Genet. Mol. Res. 10(4): 4034-4040. https://doi.org/10.4238/2011.November.8.5
3,665 views

Abstract

Preeclampsia continues to be a mortal disease of pregnant women throughout the world. Recently, geneticists, allied with obstetricians, have opened new frontiers. MicroRNAs (miRNAs) are members of a class of small, noncoding RNA molecules. They are critical posttranscriptional regulators of gene expression. We extracted circulating miRNA from maternal plasma and quantified mir-152 and mir-210. We found up-regulated miR-210 levels as well as down-regulated mir-152 levels in preeclampsia patients.We propose that detection of increased mir-210 levels in maternal serum could be used to improve prediction methods for noninvasive prenatal diagnosis of preeclampsia.

Preeclampsia continues to be a mortal disease of pregnant women throughout the world. Recently, geneticists, allied with obstetricians, have opened new frontiers. MicroRNAs (miRNAs) are members of a class of small, noncoding RNA molecules. They are critical posttranscriptional regulators of gene expression. We extracted circulating miRNA from maternal plasma and quantified mir-152 and mir-210. We found up-regulated miR-210 levels as well as down-regulated mir-152 levels in preeclampsia patients.We propose that detection of increased mir-210 levels in maternal serum could be used to improve prediction methods for noninvasive prenatal diagnosis of preeclampsia.